Delivery Order SPE2DB22D3016-SPE2DB25FAEU7

Award Date 11/27/24
Potential Completion Date 11/29/24
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of 4,565,802,734 units of Metoprolol Succinate Extended-Release 100 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,308.84 and a period of performance through September 16, 2024. AmerisourceBergen, a for-profit organization, is not subject to any set-aside requirements for this award. The company...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $1,237.68 firm fixed price delivery order is for the supply of 4,566,307,621 tablets of the cardiovascular medication Metoprolol Succinate Extended Release 100 mg. The contract has a completion date of November 4, 2024. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical products and supplies to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,100.56 firm fixed-price contract is for the delivery of 4,564,184,960 tablets of Metoprolol Succinate Extended-Release 100 mg. The contract has an ultimate completion date of April 8, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a Delivery Order for $2,363.75 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,565,665,154 units of the medication Metoprolol Succinate Extended Release 50mg Tablets, which are critical medical commodities used to support military treatment programs and federal healthcare providers. This award is under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a $1,785.84 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for Metoprolol Succinate Extended-Release 25 mg tablets, with an ultimate completion date of June 10, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $2,029.38 firm fixed-price delivery order is for the supply of 4,560,481,760 units of Metoprolol Succinate ER 100 mg tablets. The contract has an ultimate completion date of March 29, 2023 and was awarded on March 28, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,246.00 firm fixed price delivery order is for the supply of 4559169460 units of Metoprolol Succinate Extended-Release 25 mg tablets. This award is not associated with a set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award is for the delivery of metoprolol succinate extended-release tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,863.39 and an ultimate completion date of September 16, 2021. It is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Metoprolol Succinate Extended-Release Tablets, 25 milligrams. The contract has a ceiling value of $1,192.20 and a period of performance through July 1, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for 1,000 units of Metoprolol Succinate Extended-Release 25 mg tablets. The fixed-price contract has a ceiling value of $35,597.09 and runs through April 15, 2025. It is not designated as a set-aside contract. Amerisourcebergen is a major pharmaceutical distributor that has a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAEU7
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,498.60, is a delivery order for the supply of Metoprolol Succinate Extended-Release 100 mg Tablets. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including for the Defense Health Agency and U.S. Coast Guard.

Generated 9/3/25, 9:44 AM